TNF and inflammatory bowel disease: Most of these studies were undertaken in patients with rheumatological IMIDs, but studies in patients with IBD also showed lower antibody titers after PPV-23 in patients receiving TNF inhibitors ± immunosuppressive therapy (azathioprine) than in those receiving mesalamine or immunosuppressive monotherapy [74,75,76,77].